SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Pfab F)
 

Search: WFRF:(Pfab F) > Heterogeneity of mo...

  • Darsow, U. (author)

Heterogeneity of molecular sensitization profiles in grass pollen allergy - implications for immunotherapy?

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • 2014-04-16
  • Wiley,2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-227738
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-227738URI
  • https://doi.org/10.1111/cea.12303DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BackgroundData on molecular allergy diagnostics in adults with grass pollen allergy with regard to conjunctival and nasal provocation test outcome and specific immunotherapy are lacking to date. ObjectiveTo assess whether molecular allergy diagnostics for grass pollen allergens could help with predicting provocation test outcomes and serve as a basis for future component-resolved specific immunotherapy. MethodsSera of 101 adults with grass pollen allergy was analysed for IgE against timothy grass pollen (Phleum pratense), rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5b, rPhl p 6, rPhl p 7, rPhl p 11 and rPhl p12 and correlated with the individuals' outcome in the nasal and conjunctival provocation tests and investigated in regard to a potential component-resolved specific immunotherapy. ResultsAn increasing number of sensitizations to timothy grass allergens was correlated to a positive reaction in the conjunctival (4.9 vs. 3.6, P=0.003) and nasal provocation tests (4.5 vs. 2.2, P=0.0175). In molecular sensitization profiles, a substantial heterogeneity was detected, with none of the patients exactly matching the allergen composition of a previously published component-resolved specific immunotherapy containing Phl p 1, Phl p 2, Phl p 5a/b and Phl p 6. The results indicate that in 95% of the patients, a proportion of 50% of timothy-IgE would be targeted with such a specific immunotherapy, while in 50% and 10% of patients, 80% and 90% of timothy-IgE would be targeted, respectively. Conclusion and Clinical RelevanceMolecular allergy diagnostics is a prerequisite for future component-resolved specific immunotherapy due to the high heterogeneity of sensitization profiles. However, of current clinical relevance is the observed correlation between the number of sensitizations and provocation test outcome.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Brockow, K. (author)
  • Pfab, F. (author)
  • Jakob, T. (author)
  • Petersson, C. J. (author)
  • Borres, M. P.Uppsala universitet,Pediatrik(Swepub:uu)magbo385 (author)
  • Ring, J. (author)
  • Behrendt, H. (author)
  • Huss-Marp, J. (author)
  • Uppsala universitetPediatrik (creator_code:org_t)

Related titles

  • In:Clinical and Experimental Allergy: Wiley44:5, s. 778-7860954-78941365-2222

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view